合成和临床前评估68个标有Ga标记的PSMA标记剂,具有改善的药理特性

Haodong Hou1, Yixiang Lin1, Yuan Pan1

  • 1Key Laboratory for Experimental Teratology of the Ministry of Education and Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.

概括

研究人员开发了新的-68 (Ga) 标记的前列腺特异性膜抗原 (PSMA) 向前列腺癌 (PCa) 诊断的标记物. 一种标记剂Ga-SDTWS01显示,与现有的药物相比,瘤可视化得到改善,脏吸收减少.